Hyderabad November 2017 : CevaPolchemPvt. Ltd announces the
launch of its highly
advanced and innovative range of CevaPoultry Vaccines, manufactured atCevaBiomune,
USA and CevaPhylaxia, Hungary. CevaSanteAnimale, based at Libourne in south of
France, is a world renowned biopharmaceutical multi-national serving the poultry,
ruminant , swine and companion animal health sector globally. Ceva acquired
major shareholding into Polchem to introduce Ceva vaccines in India and promote
the biosecurity range of products globally from India. Ceva’s primary thrust on
hatchery vaccination in broilers has been well appreciated by Indian broilers
integrators. The first wave of vaccines getting final approval from Indian
regulations comprises of immune complex vaccines against gumboro disease ,
Transmune IBD and a HVT vectored vaccine against Ranikhet
disease,
VectormuneND
respectively. These two hatchery vaccines offer strong and comprehensive
protection for broilers against IBD and ND. CevaPolchem is also launching a
distinguished vaccination service equipment (VSE) programme to enable key
clients with most accurate, safe and efficacious hatchery vaccination
technology. Veterinary services, laboratory and advanced molecular diagnostic
services will add tremendous value to Ceva vaccines program
through correct mapping of infection pressure and immune status across India.
No comments:
Post a Comment